We are live on ! Find out more
DARE icon

Dare Bioscience
DARE

14 hedge funds and large institutions have $726K invested in Dare Bioscience in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

0% more funds holding

Funds holding: 14 → 14 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.15% less ownership

Funds ownership: 0.58% → 0.43% (-0.15%)

34% less capital invested

Capital invested by funds: $1.1M → $726K (-$378K)

Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$40.7K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$38.2K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$31.6K
4
FFS
Founders Financial Securities
Maryland
+$19.8K
5
VF
Virtu Financial
New York
+$18.8K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$65K
2
TSS
Two Sigma Securities
New York
-$29K
3
BFM
Boothbay Fund Management
New York
-$26K
4
Citadel Advisors
Citadel Advisors
Florida
-$23K
5
UBS Group
UBS Group
Switzerland
-$7.07K
Name Holding Trade Value Shares
Change 		Change in
Stake
PVMCV
1
Polaris Venture Management Co V
Massachusetts
$277K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$187K +$40.7K +3,425 +23%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$122K +$38.2K +3,216 +37%
Vanguard Group
4
Vanguard Group
Pennsylvania
$48K +$9.9K +833 +21%
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$36K +$31.6K +2,658 +293%
FFS
6
Founders Financial Securities
Maryland
$17K +$19.8K +1,667 New
VF
7
Virtu Financial
New York
$16K +$18.8K +1,586 New
Northern Trust
8
Northern Trust
Illinois
$9K – – –
UCFA
9
United Capital Financial Advisors
Texas
$9K +$10.1K +854 New
EWM
10
Edge Wealth Management
New York
$3K +$2.97K +250 New
BlackRock
11
BlackRock
New York
$1K – – –
AWA
12
Artemis Wealth Advisors
New York
$749 – – –
Jane Street
13
Jane Street
New York
– -$65K -3,844 Closed
TSS
14
Two Sigma Securities
New York
– -$29K -1,753 Closed
BFM
15
Boothbay Fund Management
New York
– -$26K -1,528 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$23K -1,355 Closed
UBS Group
17
UBS Group
Switzerland
– -$7.07K -595 -98%

DARE Hedge Fund Activity: Q2 2019 in Review

14 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2019, worth a combined $726K — down 34% from $1.1M a quarter earlier.

Fund positioning in DARE was balanced in Q2 2019: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $40.7K. The largest seller was Jane Street, exiting entirely with an estimated $65K sold.

  • 14 institutional investors held Dare Bioscience (DARE) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $726K of Dare Bioscience stock for Q2 2019, down 34% quarter-over-quarter.
  • 4 funds opened new Dare Bioscience positions in Q2 2019 and 4 closed out, a net change of 0 holders.
  • The largest Dare Bioscience buyer in Q2 2019 was Renaissance Technologies, an estimated $40.7K added.
  • The largest Dare Bioscience seller in Q2 2019 was Jane Street, an estimated $65K sold.

Based on aggregated 13F filings for Q2 2019.